Table 1.
No ACEi/ARB | ACEi/ARB | |
Baseline characteristics | ||
N | ||
Mean age ±SD (years) | ||
Sex, n | ||
Men | ||
Women | ||
Medical history, n | ||
Hypertension | ||
Diabetes | ||
Chronic kidney disease | ||
Cardiovascular disease | ||
Chronic obstructive pulmonary disease | ||
Smoking | ||
Ever-smoked | ||
Non-smoker | ||
Outcomes for ≤30 days | ||
Total no of patients in the group, n | ||
All-cause mortality | ||
Myocardial Infarction | ||
Congestive cardiac failure | ||
Revascularisation | ||
Admission to intensive care unit | ||
Need for mechanical ventilation | ||
Hospitalisation (if outpatient study) | ||
Pulmonary embolism/deep vein thrombosis | ||
Acute kidney injury | ||
Outcomes >1 month, n | ||
All-cause mortality |
*N=number, SD, ACEi, ARB; acute kidney injury: decline in kidney function or urine output from baseline.
ACEi, ACE inhibitors; ARB, angiotensin II receptor blocker; eGFR, estimated glomerular filtration rate; MeSH, medical subject headings.